210 related articles for article (PubMed ID: 26218492)
21. Knowledge, attitudes, and practices toward cervical cancer prevention among women in Kampong Speu Province, Cambodia.
Touch S; Oh JK
BMC Cancer; 2018 Mar; 18(1):294. PubMed ID: 29544466
[TBL] [Abstract][Full Text] [Related]
22. Sociodemographic predictors of HPV testing and vaccination acceptability: results from a population-representative sample of British women.
Marlow LA; Waller J; Wardle J
J Med Screen; 2008; 15(2):91-6. PubMed ID: 18573777
[TBL] [Abstract][Full Text] [Related]
23. Primary HPV testing versus cytology-based cervical screening in women in Australia vaccinated for HPV and unvaccinated: effectiveness and economic assessment for the National Cervical Screening Program.
Lew JB; Simms KT; Smith MA; Hall M; Kang YJ; Xu XM; Caruana M; Velentzis LS; Bessell T; Saville M; Hammond I; Canfell K
Lancet Public Health; 2017 Feb; 2(2):e96-e107. PubMed ID: 29253402
[TBL] [Abstract][Full Text] [Related]
24. [Sexual risk behaviours and PAP testing in university women vaccinated against human papillomavirus].
Fernández-Feito A; Antón-Fernández R; Paz-Zulueta M
Aten Primaria; 2018 May; 50(5):291-298. PubMed ID: 28867156
[TBL] [Abstract][Full Text] [Related]
25. HPV vaccination leads to decrease of anogenital warts and precancerous lesions of the cervix uteri in young women with low vaccination rates: a retrospective cohort analysis.
Osmani V; Fett S; Tauscher M; Donnachie E; Schneider A; Klug SJ
BMC Cancer; 2022 Dec; 22(1):1293. PubMed ID: 36494790
[TBL] [Abstract][Full Text] [Related]
26. High-Risk Human Papillomavirus (HPV) Infection and Cervical Cancer Prevention in Britain: Evidence of Differential Uptake of Interventions from a Probability Survey.
Tanton C; Soldan K; Beddows S; Mercer CH; Waller J; Field N; Clifton S; Copas AJ; Panwar K; Manyenga P; da Silva F; Wellings K; Ison CA; Johnson AM; Sonnenberg P
Cancer Epidemiol Biomarkers Prev; 2015 May; 24(5):842-53. PubMed ID: 25737331
[TBL] [Abstract][Full Text] [Related]
27. HPV Vaccination and the Risk of Invasive Cervical Cancer.
Lei J; Ploner A; Elfström KM; Wang J; Roth A; Fang F; Sundström K; Dillner J; Sparén P
N Engl J Med; 2020 Oct; 383(14):1340-1348. PubMed ID: 32997908
[TBL] [Abstract][Full Text] [Related]
28. Adapting cervical cancer screening for women vaccinated against human papillomavirus infections: The value of stratifying guidelines.
Pedersen K; Burger EA; Nygård M; Kristiansen IS; Kim JJ
Eur J Cancer; 2018 Mar; 91():68-75. PubMed ID: 29335156
[TBL] [Abstract][Full Text] [Related]
29. Prediction of cervical cancer incidence in England, UK, up to 2040, under four scenarios: a modelling study.
Castanon A; Landy R; Pesola F; Windridge P; Sasieni P
Lancet Public Health; 2018 Jan; 3(1):e34-e43. PubMed ID: 29307386
[TBL] [Abstract][Full Text] [Related]
30. Real-world effectiveness of HPV vaccination against cervical neoplasia among birth cohorts ineligible for routine vaccination.
Dong L; Nygård M; Støer NC; Klungsøyr O; Hansen BT
Int J Cancer; 2023 Jul; 153(2):399-406. PubMed ID: 36866965
[TBL] [Abstract][Full Text] [Related]
31. Exacerbating disparities?: Cervical cancer screening and HPV vaccination.
Silver MI; Kobrin S
Prev Med; 2020 Jan; 130():105902. PubMed ID: 31730943
[TBL] [Abstract][Full Text] [Related]
32. Sexual behavior, clinical outcomes and attendance of cervical cancer screening by HPV vaccinated and unvaccinated sexually active women.
Sauvageau C; Gilca V; Ouakki M; Kiely M; Coutlée F; Mathieu-Chartier S; Defay F; Lambert G
Hum Vaccin Immunother; 2021 Nov; 17(11):4393-4396. PubMed ID: 34410872
[TBL] [Abstract][Full Text] [Related]
33. Quadrivalent HPV vaccine effectiveness against high-grade cervical lesions by age at vaccination: A population-based study.
Herweijer E; Sundström K; Ploner A; Uhnoo I; Sparén P; Arnheim-Dahlström L
Int J Cancer; 2016 Jun; 138(12):2867-74. PubMed ID: 26856527
[TBL] [Abstract][Full Text] [Related]
34. Knowledge and Attitude Toward Human Papillomavirus Infection and Vaccination among Thai Women: A Nationwide Social Media Survey.
Likitdee N; Kietpeerakool C; Chumworathayi B; Temtanakitpaisan A; Aue-Aungkul A; Nhokaew W; Jampathong N
Asian Pac J Cancer Prev; 2020 Oct; 21(10):2895-2902. PubMed ID: 33112546
[TBL] [Abstract][Full Text] [Related]
35. Effectiveness of HPV vaccination against high grade cervical lesions in Japan.
Konno R; Konishi H; Sauvaget C; Ohashi Y; Kakizoe T
Vaccine; 2018 Dec; 36(52):7913-7915. PubMed ID: 29778520
[TBL] [Abstract][Full Text] [Related]
36. Use of HPV testing for cervical screening in vaccinated women--Insights from the SHEVa (Scottish HPV Prevalence in Vaccinated Women) study.
Bhatia R; Kavanagh K; Cubie HA; Serrano I; Wennington H; Hopkins M; Pan J; Pollock KG; Palmer TJ; Cuschieri K
Int J Cancer; 2016 Jun; 138(12):2922-31. PubMed ID: 26845632
[TBL] [Abstract][Full Text] [Related]
37. Effects of numerical information on intention to participate in cervical screening among women offered HPV vaccination: a randomised study.
Hestbech MS; Gyrd-Hansen D; Kragstrup J; Siersma V; Brodersen J
Scand J Prim Health Care; 2016 Dec; 34(4):401-419. PubMed ID: 27845597
[TBL] [Abstract][Full Text] [Related]
38. Spontaneous preterm birth risk among HPV-vaccinated and -unvaccinated women: a nationwide retrospective cohort study of over 240 000 singleton births.
McClymont E; Faber MT; Belmonte F; Kjaer SK
BJOG; 2023 Mar; 130(4):358-365. PubMed ID: 36424904
[TBL] [Abstract][Full Text] [Related]
39. Real-World Effectiveness of Human Papillomavirus Vaccination Against Vulvovaginal High-Grade Precancerous Lesions and Cancers.
Dehlendorff C; Baandrup L; Kjaer SK
J Natl Cancer Inst; 2021 Jul; 113(7):869-874. PubMed ID: 33377930
[TBL] [Abstract][Full Text] [Related]
40. Real-World Effectiveness of Human Papillomavirus Vaccination Against Cervical Cancer.
Kjaer SK; Dehlendorff C; Belmonte F; Baandrup L
J Natl Cancer Inst; 2021 Oct; 113(10):1329-1335. PubMed ID: 33876216
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]